1. Home
  2. APYX vs ATRA Comparison

APYX vs ATRA Comparison

Compare APYX & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

HOLD

Current Price

$2.48

Market Cap

107.4M

Sector

Health Care

ML Signal

HOLD

Logo Atara Biotherapeutics Inc.

ATRA

Atara Biotherapeutics Inc.

HOLD

Current Price

$9.32

Market Cap

94.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APYX
ATRA
Founded
1982
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.4M
94.2M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
APYX
ATRA
Price
$2.48
$9.32
Analyst Decision
Strong Buy
Buy
Analyst Count
6
3
Target Price
$6.50
★ $13.67
AVG Volume (30 Days)
★ 164.2K
28.1K
Earning Date
11-05-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
19.40
★ 122.52
EPS
★ N/A
N/A
Revenue
N/A
★ $120,772,000.00
Revenue This Year
$12.42
N/A
Revenue Next Year
$11.05
$1,334.59
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.32
$3.92
52 Week High
$5.08
$19.15

Technical Indicators

Market Signals
Indicator
APYX
ATRA
Relative Strength Index (RSI) 39.93 52.13
Support Level $2.33 $8.94
Resistance Level $2.73 $9.93
Average True Range (ATR) 0.15 0.61
MACD 0.01 0.00
Stochastic Oscillator 37.18 64.37

Price Performance

Historical Comparison
APYX
ATRA

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.

Share on Social Networks: